Thoratec Corporation

Thoratec Corporation is a medical device company that develops products to support patients with severe heart failure. Its main offerings include ventricular assist devices (VADs), which are mechanical pumps that help the heart pump blood when it’s too weak to do so on its own. These devices are used as a temporary solution while waiting for a heart transplant or as a long-term treatment. Thoratec’s innovations aim to improve quality of life and survival for patients with advanced heart disease. The company was acquired by Abbott Laboratories in 2017 but remains known for its vital cardiovascular support technologies.